Rixubis Recommended by EMA Panel for Hemophilia BRixubis Recommended by EMA Panel for Hemophilia B
Rixubis has been recommended by the European Medicines Agency's Committee for Medicinal Products for Human Use for prophylaxis and treatment of bleeding in patients with hemophilia B. International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Bleeding | Cancer & Oncology | European Medicines Agency (EMA) | Haemophilia | Health | Hematology | Hemophilia